Aldevron, a global leader in the custom development and manufacture of plasmid DNA, protein, mRNA and antibodies for the biotech industry, is hosting its second Breakthrough Symposium with the theme “Pioneering Biotech,” September 28-30, 2020, in Fargo, N.D., home to Aldevron’s headquarters and main campus.
The three-day Breakthrough Symposium will welcome scientific speakers focused on pioneering advances and innovative technologies in gene and cell therapies, genetic and regenerative medicine, gene editing and more. Additionally, patients and advocates will speak on these advancements and how they are transforming medicine.
Organized by Aldevron, the symposium will feature several distinguished industry and academic researchers such as Stephen Johnston, Ph.D., Center Director and Professor, Biodesign Center for Innovations in Medicine, Arizona State University; Jill Weimer, Senior VP of Discovery Science, Amicus Therapeutics and Senior Director of Therapeutic Development, Sanford Research; and Nicole Boice, Co-Founder, RARE-X, and Founder, Global Genes.
“Aldevron is honored to work with some of the most innovative companies, academic institutions, and government laboratories in biotechnology today. Our focus continues to be our clients and the patients they serve, and we are proud to provide a platform to bring these two communities together,” said Michael Chambers, Aldevron’s CEO. “The theme “pioneering” is a nod not only to our industry, but to Aldevron’s home base. North Dakota is guided by a pioneering spirit, making it the perfect place for to host a conference focused on how we continue to make breakthroughs throughout the industry.”
To learn more about the current line-up of speakers, submit a poster abstract or to register, visit BreakthroughSymposium.com